Lotus Pharmaceutical Co., Ltd.

TWSE:1795.TW

282 (TWD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q1
Revenue 5,234.2044,742.9284,198.1443,419.0984,573.174,441.8434,523.863,171.595,389.3732,910.4323,161.3772,802.9033,057.783,464.1173,324.3893,130.9382,886.2992,676.9131,962.5323,128.2741,969.9311,893.8642,182.6711,722.5951,581.2331,635.2821,489.7841,831.0891,579.1291,577.431,436.1121,479.3561,403.6031,594.3321,425.2751,472.6411,417.451,337.3981,294.448660.898584.861145.074128.019214.218152.459132.024159.78134.952150.8115.315102.086170.681124.349115.8121.379161.193140.231151.082137.678
Cost of Revenue 1,918.7042,122.4171,894.6492,269.5291,925.4881,836.1381,816.3871,772.4241,732.3841,531.0751,790.741,492.8411,673.1912,015.4761,827.5611,800.8871,630.9081,600.0111,061.8371,954.16938.727930.4021,103.58865.178765.335852.397806.504954.928795.802829.64763.716684.662596.618647.382645.875622.451544.02577.163549.515336.556312.3774.19666.37987.0754.48456.751.14559.89849.10363.30456.20456.76256.58946.21845.14258.8750.65757.47668.657
Gross Profit 3,315.52,620.5112,303.4951,149.5692,647.6822,605.7052,707.4731,399.1663,656.9891,379.3571,370.6371,310.0621,384.5891,448.6411,496.8281,330.0511,255.3911,076.902900.6951,174.1141,031.204963.4621,079.091857.417815.898782.885683.28876.161783.327747.79672.396794.694806.985946.95779.4850.19873.43760.235744.933324.342272.49170.87861.64127.14897.97575.324108.63575.054101.69752.01145.882113.91967.7669.58276.237102.32389.57493.60669.021
Gross Profit Ratio 0.6330.5530.5490.3360.5790.5870.5980.4410.6790.4740.4340.4670.4530.4180.450.4250.4350.4020.4590.3750.5230.5090.4940.4980.5160.4790.4590.4780.4960.4740.4680.5370.5750.5940.5470.5770.6160.5680.5750.4910.4660.4890.4810.5940.6430.5710.680.5560.6740.4510.4490.6670.5450.6010.6280.6350.6390.620.501
Reseach & Development Expenses 150.848222.954116.978191.914235.165128.724165.023109.314202.664107.866100.605221.856121.653174.7577.666155.568173.21485.80590.792206.856135.298125.09586.3287.93875.75173.18588.06290.54391.06569.65378.262232.84490.21566.09363.02396.6296.53657.35645.5669138.362123.12858.0865.37363.49832.23129.12566.84337.35887.39840.82480.73667.93460.27628.97125.13824.85826.45220.35
General & Administrative Expenses 393.457356.088335.845409.936301.867255.163257.102325.581268.359252.334206.981233.589177.928211.033283.233228.916265.373217.573185.719227.423197.876193.476168.298175.682174.733165.305165.889226.869146.66160.021146.902131.61227.403225.584142.142183.943136.708156.535178.688407.724299.03720.19625.8231.1512.91814.62212.61124.32115.16315.73113.44112.45615.56813.611.12313.42219.28216.80212.088
Selling & Marketing Expenses 670.609662.877595.965677.023633.646608.729620.615606.45544.926531.004442.285459.281478.885453.206417.376501.509374.334355.985332.197490.094406.372518.511378.632495.411384.115444.393360.328451.317378.099350.393366.801617.449411.211450.149425.923443.939478.133455.257450.29148.3443.40663.01343.56156.28738.5184434.0451.67942.92844.39339.80844.66647.00449.92141.10840.36139.72144.61148.677
SG&A 1,064.0661,022.816931.81814.257935.513863.892877.717932.031813.285783.338649.266692.87656.813664.239700.609730.425639.707573.558517.916717.517604.248711.987546.93671.093558.848609.698526.217678.186524.759510.414513.703749.059638.614675.733568.065627.882614.841611.792628.978556.064342.44383.20969.38187.43751.43658.62246.6517658.09160.12453.24957.12262.57263.52152.23153.78359.00361.41360.765
Other Expenses 2,100.5860179.973507.618209.63840.892-32.31650.50692.19721.91543.4320.029-37.296-45.117-51.52931.538-3.59835.074-32.7638.82923.14630.11310.67930.14612.447-26.89319.04115.37317.4541.803-87.15915.97110.545-12.45538.80319.57822.237122.0150.672-15.373-1.7212.73412.4823.40831.7430.064-1.2813.654-1.8499.4251.3552.133.1393.063.6824.621.2488.1473.889
Operating Expenses 3,315.51,245.771,048.7881,006.1711,170.678992.6161,042.741,041.3451,015.949891.204749.871914.726778.466838.989778.275885.993812.921659.363608.708924.373739.546837.082633.25759.031634.599682.883614.279768.729615.824580.067591.965981.903728.829741.826631.088724.502711.377669.148674.544642.536382.997206.337127.461152.81114.93490.85375.776142.84395.449147.52294.073137.858130.506123.79781.20278.92183.86187.86581.115
Operating Income 2,100.5861,633.2211,456.785143.3981,697.2261,658.8431,633.593409.6772,734.183510.651664.827395.445606.123609.652718.553444.058442.47417.539291.987249.741291.658126.38445.84198.386181.299100.00269.001107.432167.503167.72380.431-187.20978.156205.124148.312125.688162.05391.08770.389-318.194-110.506-135.459-65.821-25.662-16.959-15.52932.859-67.7896.248-95.511-48.191-23.939-62.746-54.215-4.96523.4025.7135.741-12.094
Operating Income Ratio 0.4010.3440.3470.0420.3710.3730.3610.1290.5070.1750.210.1410.1980.1760.2160.1420.1530.1560.1490.080.1480.0670.2040.0570.1150.0610.0460.0590.1060.1060.056-0.1270.0560.1290.1040.0850.1140.0680.054-0.481-0.189-0.934-0.514-0.12-0.111-0.1180.206-0.5020.041-0.828-0.472-0.14-0.505-0.468-0.0410.1450.0410.038-0.088
Total Other Income Expenses Net -202.62327.752-150.436364.791-130.931-89.22-160.161-63.027-11.001-61.362-32.178-75.097-133.475-125.881-125.192-39.221-79.477-42.246-130.875-57.894-72.27-50.835-55.299-67.427-58.242-109.147-50.168-51.721-50.659-61.567-148.328-51.359-59.778-83.502-30.484-64.439-60.19929.268-48.602-34.988-5.1623.005-81.97221.553-39.521-1.675-2.978-16.6-5.1936.0911.83743.001-54.077123.6640.708-0.705-1.12511.4393.145
Income Before Tax 1,897.9631,660.9731,306.349508.1891,566.2951,523.8691,504.572294.7942,630.039426.791588.588320.239472.648483.771593.361404.837362.993375.293158.681191.847223.94871.627388.99830.959123.057-9.14518.83355.711116.844106.156-67.897-238.56818.378121.622117.82861.249101.854119.97721.787-353.182-115.666-135.028-55.625-4.10913.619-17.20429.881-84.3891.055-89.421-38.22919.062-116.82369.449-4.25722.6974.58817.18-8.949
Income Before Tax Ratio 0.3630.350.3110.1490.3420.3430.3330.0930.4880.1470.1860.1140.1550.140.1780.1290.1260.140.0810.0610.1140.0380.1780.0180.078-0.0060.0130.030.0740.067-0.047-0.1610.0130.0760.0830.0420.0720.090.017-0.534-0.198-0.931-0.435-0.0190.089-0.130.187-0.6250.007-0.775-0.3740.112-0.9390.6-0.0350.1410.0330.114-0.065
Income Tax Expense 332.852329.403270.053108.231320.39258.029310.649127.188550.66499.119142.48468.606124.371129.193144.47886.76984.18776.63826.9952.60223.9319.638101.967-41.92548.03839.652-6.14959.80647.75248.6325.806-20.85338.13367.26727.25820.58685.266-5.20742.933-96.121-11.48-12.961-4.78910.9959.13-10.2180.398-7.654-0.659-5.577-2.33616.443-5.739-2.885-1.9855.1943.17710.1011.993
Net Income 1,565.1111,331.571,036.296399.9581,245.9051,265.841,193.923167.6062,079.375327.672446.104251.633348.277354.578448.883317.951278.718298.619131.508139.322199.60248.461275.42272.09367.381-55.50615.508-3.25348.41934.873-72.354-182.366-32.31516.81863.82229.71715.15689.364-30.288-176.411-86.235-122.067-50.836-15.1044.489-6.98629.483-76.7351.714-83.844-35.8932.619-111.08472.334-2.27217.5031.4117.079-10.942
Net Income Ratio 0.2990.2810.2470.1170.2720.2850.2640.0530.3860.1130.1410.090.1140.1020.1350.1020.0970.1120.0670.0450.1010.0260.1260.0420.043-0.0340.01-0.0020.0310.022-0.05-0.123-0.0230.0110.0450.020.0110.067-0.023-0.267-0.147-0.841-0.397-0.0710.029-0.0530.185-0.5690.011-0.727-0.3520.015-0.8930.625-0.0190.1090.010.047-0.079
EPS 5.985.093.961.514.764.854.580.647.971.261.720.971.341.381.851.311.151.230.540.570.820.21.160.30.28-0.230.07-0.0140.20.15-0.3-0.79-0.140.070.270.120.060.37-0.13-0.9-0.44-1.65-0.34-0.26-0.32-0.120.52-1.70.038-1.79-0.770.054-2.291.49-0.0470.360.0290.16-0.24
EPS Diluted 5.955.063.941.514.754.844.550.637.931.251.710.971.331.381.841.311.151.230.540.570.820.21.160.30.28-0.230.07-0.0130.20.15-0.3-0.79-0.140.070.270.120.060.37-0.13-0.9-0.44-1.65-0.34-0.26-0.32-0.120.51-1.70.038-1.79-0.770.054-2.291.49-0.0470.360.0290.16-0.24
EBITDA 2,366.5031,944.3021,773.309989.0071,989.6711,953.3781,934.187655.8182,974.264750.82873.823589.613732.152751.106853.368663.43623.434631.586424.129445.202460.689303.506593.102222.32293.505174.85183.733225.321275.758258.21971.259-93.632168.23270.996256.034214.051258.568290.33195.519-273.951-62.994-116.146-37.11318.19830.9521.06748.703-65.28319.74-71.003-33.7629.499-58.896-36.9346.53726.7695.62123.891-2.449
EBITDA Ratio 0.4520.410.4220.1360.4350.440.4280.2070.5520.2580.2760.2110.2470.2180.2580.2110.2170.2370.2160.1420.2340.160.2720.1290.1850.1070.1240.1230.1750.1640.052-0.0620.120.170.180.1450.1820.2190.151-0.415-0.071-0.801-0.290.0850.2030.0080.305-0.3450.131-0.615-0.3310.173-0.474-0.3190.0570.1660.040.158-0.017